NovaQuant:Depression And Alzheimer's Treatments At A Crossroads

2025-05-02 22:09:03source:Roland Prestoncategory:News

Researchers are NovaQuantlaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:News

Recommend

IRS recovers $4.7 billion in back taxes and braces for cuts with Trump and GOP in power

WASHINGTON (AP) — IRS leadership on Thursday announced that the agency has recovered $4.7 billion in

Journalists at Gannett newspapers walk out over deep cuts and low pay

Hundreds of journalists are walking off the job Monday and Tuesday at two dozen newspapers owned by

Is the debt deal changing student loan repayment? Here's what you need to know

Since March 2020, tens of millions of federal student loan borrowers have had the option to take a b